TSXV:CVM.H - Post by User
Comment by
OleMuleon Aug 17, 2020 2:32pm
153 Views
Post# 31419045
RE:RE:RE:Blunden
RE:RE:RE:BlundenOldtimer
I also found it odd that not one mention of any of the clinical trial sites was included in the MD&A. One can only assume the trials have all been halted as no funds to pay. Also no mention of Canon either. We shall see but I think their estimate of Q12022 is just that, a placeholder that more than likely will get adjusted based upon the success of many other things that truly have to happen (restructuring) that would be approved by the shareholders prior to any meaningful milestone dates being posted.